impact factor, citescore
logo
 

Paediatric Rheumatology

 

SUPERIOR EFFICACY OF ADALIMUMAB IN TREATING CHILDHOOD REFRACTORY CHRONIC UVEITIS WHEN USED AS FIRST BIOLOGIC MODIFIER DRUG: A MULTICENTRIC OPEN-LABEL COMPARATIVE STUDY


, , , , , , , ,

 

CER5731
Paediatric Rheumatology

Received: 30/05/2012
Accepted : 30/08/2012
In Press: 30/05/2012

Rheumatology Article